Publications
Detailed Information
Minocycline and neurodegenerative diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hye-Sun | - |
dc.contributor.author | Suh, Yoo-Hun | - |
dc.date.accessioned | 2012-07-03T00:32:28Z | - |
dc.date.available | 2012-07-03T00:32:28Z | - |
dc.date.issued | 2009-01-23 | - |
dc.identifier.citation | BEHAVIOURAL BRAIN RESEARCH; Vol.196 2; 168-179 | ko_KR |
dc.identifier.issn | 0166-4328 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78158 | - |
dc.description.abstract | Minocycline is a semi-synthetic, second-gene ration tetracycline analog which is effectively crossing the blood-brain barrier, effective against gram-positive and -negative infections. In addition to its own antimicrobacterial properties, minocycline has been reported to exert neuroprotective effects over various experimental models such as cerebral ischemia, traumatic brain injury, amyotrophic lateral sclerosis, Parkinson`s disease, kainic acid treatment, Huntington`s disease and multiple sclerosis. Minocycline has been focused as a neuroprotective agent over neurodegenerative disease since it has been first reported that minocycline has neuroprotective effects in animal models of ischemic injury [Yrjanheikki J, Keinanen R, Pellikka M. Hokfelt T, Koisinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 1998;95:15769-74; Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999;96:13496-500]. Recently, the effect of minocycline on Alzheimer`s disease has been also reported. Although its precise primary target is not clear, the action mechanisms of minocycline for neuro-protection reported so far are; via; the inhibition of mitochondrial permeability-transition mediated cytochrome c release from mitochondria, the inhibition of caspase-1 and -3 expressions, and the suppression of microglial activation, involvement in some signaling pathways, metalloprotease activity inhibition. Because of the high tolerance and the excellent penetration into the brain, minocycline has been clinically tried for some neurodegenerative diseases such as stroke, multiple sclerosis, spinal cord injury, amyotropic lateral sclerosis, Hungtington`s disease and Parkinson`s disease. This review will briefly summarize the effects and action mechanisms of minocycline on neurodegenerative diseases. (C) 2008 Elsevier B.V. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER SCIENCE BV | ko_KR |
dc.subject | Minocycline | ko_KR |
dc.subject | Spinal cord injury | ko_KR |
dc.subject | Parkinson`s disease | ko_KR |
dc.subject | Huntington`s disease | ko_KR |
dc.subject | Ischemia | ko_KR |
dc.subject | Amyotropic lateral sclerosis | ko_KR |
dc.subject | Neurodegenerative diseases | ko_KR |
dc.subject | Alzheimer`s disease | ko_KR |
dc.title | Minocycline and neurodegenerative diseases | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김혜선 | - |
dc.contributor.AlternativeAuthor | 서유헌 | - |
dc.identifier.doi | 10.1016/j.bbr.2008.09.040 | - |
dc.citation.journaltitle | BEHAVIOURAL BRAIN RESEARCH | - |
dc.description.citedreference | Burgos-Ramos E, 2008, NEUROSCIENCE, V154, P1458, DOI 10.1016/j.neuroscience.2008.04.036 | - |
dc.description.citedreference | Ruggieri M, 2008, J NEUROIMMUNOL, V197, P140, DOI 10.1016/j.jneuroim.2008.04.032 | - |
dc.description.citedreference | Keilhoff G, 2008, EXP NEUROL, V212, P189, DOI 10.1016/j.expneurol.2008.03.028 | - |
dc.description.citedreference | Pae CU, 2008, BIOMED PHARMACOTHER, V62, P308, DOI 10.1016/j.biopha.2007.12.005 | - |
dc.description.citedreference | Iyirhiaro GO, 2008, J NEUROCHEM, V105, P703, DOI 10.1111/j.1471-4159.2007.05166.x | - |
dc.description.citedreference | Haines JD, 2008, J MOL NEUROSCI, V35, P23, DOI 10.1007/s12031-007-9011-0 | - |
dc.description.citedreference | FILIPOVIC R, 2008, EXP NEUROL, V211, P41 | - |
dc.description.citedreference | RACETTE B, 2008, CLIN NEUROPHARMACOL, V31, P141 | - |
dc.description.citedreference | ELKELENBOOM P, 2008, NEURODEGENER DIS, V5, P190 | - |
dc.description.citedreference | LUCCARINI H, 2008, EXP NEUROL, V211, P214 | - |
dc.description.citedreference | Guo G, 2007, NEUROCHEM RES, V32, P2160, DOI 10.1007/s11064-007-9408-8 | - |
dc.description.citedreference | Garcia-Alloza M, 2007, NEUROBIOL DIS, V28, P286 | - |
dc.description.citedreference | Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377 | - |
dc.description.citedreference | Tang MN, 2007, J NUCL MED, V48, P1822, DOI 10.2967/jnumed.107.041335 | - |
dc.description.citedreference | Lampl Y, 2007, NEUROLOGY, V69, P1404 | - |
dc.description.citedreference | Yune TY, 2007, J NEUROSCI, V27, P7751, DOI 10.1523/JNEUROSCI.1661-07.2007 | - |
dc.description.citedreference | Familian A, 2007, NEUROSCI LETT, V416, P87, DOI 10.1016/j.neulet.2007.01.052 | - |
dc.description.citedreference | Sanchez EC, 2007, NEUROL RES, V29, P184, DOI 10.1179/016164107X18124 | - |
dc.description.citedreference | Reynolds N, 2007, MOVEMENT DISORD, V22, P292, DOI 10.1002/mds.21199 | - |
dc.description.citedreference | Mansson R, 2007, NEUROBIOL DIS, V25, P198, DOI 10.1016/j.nbd.2006.09.008 | - |
dc.description.citedreference | Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7 | - |
dc.description.citedreference | MARIER K, 2007, NEUROBIOL DIS, V25, P514 | - |
dc.description.citedreference | GORDON PH, 2007, LANCET NEUROL, P1045 | - |
dc.description.citedreference | Peng J, 2006, J NEUROSCI, V26, P11644, DOI 10.1523/JNEUROSCI.3447-06.2006 | - |
dc.description.citedreference | Traynor BJ, 2006, NEUROLOGY, V67, P20 | - |
dc.description.citedreference | Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x | - |
dc.description.citedreference | Heo K, 2006, NEUROSCI LETT, V398, P195, DOI 10.1016/j.neulet.2006.01.027 | - |
dc.description.citedreference | Casarejos MJ, 2006, J NEUROCHEM, V97, P934 | - |
dc.description.citedreference | Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338 | - |
dc.description.citedreference | Ryu JK, 2006, EXP NEUROL, V198, P552, DOI 10.1016/j.expneurol.2005.12.016 | - |
dc.description.citedreference | Stack EC, 2006, BBA-MOL BASIS DIS, V1762, P373, DOI 10.1016/j.bbadis.2005.11.002 | - |
dc.description.citedreference | Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004 | - |
dc.description.citedreference | Familian A, 2006, GLIA, V53, P233, DOI 10.1002/glia.20268 | - |
dc.description.citedreference | RYU JK, 2006, NEUROSCIENCE, V141, P1836 | - |
dc.description.citedreference | Stirling DR, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175 | - |
dc.description.citedreference | Yong VW, 2004, LANCET NEUROL, V3, P744 | - |
dc.description.citedreference | Bonelli RM, 2004, INT CLIN PSYCHOPHARM, V19, P337 | - |
dc.description.citedreference | Ryu JK, 2004, GLIA, V48, P85, DOI 10.1002/glia.20051 | - |
dc.description.citedreference | Suk K, 2004, NEUROSCI LETT, V366, P167, DOI 10.1016/j.neulet.2004.05.038 | - |
dc.description.citedreference | Thomas M, 2004, MOVEMENT DISORD, V19, P692, DOI 10.1002/mds.20018 | - |
dc.description.citedreference | Hunter CL, 2004, EUR J NEUROSCI, V19, P3305, DOI 10.1111/j.1460-9568.2004.03439.x | - |
dc.description.citedreference | Gordon PH, 2004, NEUROLOGY, V62, P1845 | - |
dc.description.citedreference | Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200 | - |
dc.description.citedreference | Ekshyyan O, 2004, FRONT BIOSCI, V9, P1567 | - |
dc.description.citedreference | Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556 | - |
dc.description.citedreference | Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004 | - |
dc.description.citedreference | Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101 | - |
dc.description.citedreference | TUSUJI M, 2004, EXP NEUROL, V189, P2580 | - |
dc.description.citedreference | Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100 | - |
dc.description.citedreference | Piao CS, 2003, J NEUROSCI RES, V73, P537, DOI 10.1002/jnr.10671 | - |
dc.description.citedreference | Chen A, 2003, NEURON, V39, P655 | - |
dc.description.citedreference | Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614 | - |
dc.description.citedreference | Good ML, 2003, BRIT J DERMATOL, V149, P237 | - |
dc.description.citedreference | Bonelli RM, 2003, NEUROLOGY, V60, P883 | - |
dc.description.citedreference | Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X | - |
dc.description.citedreference | ROBERT MF, 2003, NEW ENGL J MED, V348, P1365 | - |
dc.description.citedreference | Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153 | - |
dc.description.citedreference | Suh YH, 2002, PHARMACOL REV, V54, P469 | - |
dc.description.citedreference | Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487 | - |
dc.description.citedreference | Brundula V, 2002, BRAIN, V125, P1297 | - |
dc.description.citedreference | Zhu S, 2002, NATURE, V417, P74 | - |
dc.description.citedreference | Wu DC, 2002, J NEUROSCI, V22, P1763 | - |
dc.description.citedreference | Ferrante RJ, 2002, J NEUROSCI, V22, P1592 | - |
dc.description.citedreference | Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092 | - |
dc.description.citedreference | Coraci IS, 2002, AM J PATHOL, V160, P101 | - |
dc.description.citedreference | BOSCH LVD, 2002, NEUROREPORT, V13, P1067 | - |
dc.description.citedreference | Du YS, 2001, P NATL ACAD SCI USA, V98, P14669 | - |
dc.description.citedreference | Lin SZ, 2001, NEUROSCI LETT, V315, P61 | - |
dc.description.citedreference | Kandel ER, 2001, SCIENCE, V294, P1030 | - |
dc.description.citedreference | Cagnin A, 2001, LANCET, V358, P461 | - |
dc.description.citedreference | He Y, 2001, BRAIN RES, V909, P187 | - |
dc.description.citedreference | Yong VW, 2001, NAT REV NEUROSCI, V2, P502 | - |
dc.description.citedreference | Tikka TM, 2001, J IMMUNOL, V166, P7527 | - |
dc.description.citedreference | Tikka T, 2001, J NEUROSCI, V21, P2580 | - |
dc.description.citedreference | Selkoe DJ, 2001, PHYSIOL REV, V81, P741 | - |
dc.description.citedreference | BACSKAI BJ, 2001, NAT MED, V7, P369 | - |
dc.description.citedreference | SANCHEZ, 2001, NEUROSURGERY, V48, P1393 | - |
dc.description.citedreference | Harding HP, 2000, MOL CELL, V6, P1099 | - |
dc.description.citedreference | Chen M, 2000, NAT MED, V6, P797 | - |
dc.description.citedreference | Short DJ, 2000, SPINAL CORD, V38, P273 | - |
dc.description.citedreference | KOMEK B, 2000, AM J PATHOL, V157, P267 | - |
dc.description.citedreference | LE YL, 2000, NEUROCHEM INT, V36, P417 | - |
dc.description.citedreference | Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496 | - |
dc.description.citedreference | Springer JE, 1999, NAT MED, V5, P943 | - |
dc.description.citedreference | Harding HP, 1999, NATURE, V397, P271 | - |
dc.description.citedreference | Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769 | - |
dc.description.citedreference | Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369 | - |
dc.description.citedreference | Trapp BD, 1998, NEW ENGL J MED, V338, P278 | - |
dc.description.citedreference | NELSON ML, 1998, ADV DENT RES, V12, P5 | - |
dc.description.citedreference | Gough A, 1996, BRIT MED J, V312, P169 | - |
dc.description.citedreference | Kloppenburg M, 1995, CLIN EXP IMMUNOL, V102, P635 | - |
dc.description.citedreference | KLEIN NC, 1995, MED CLIN N AM, V79, P789 | - |
dc.description.citedreference | PRICE C, 1994, AM J EPIDEMIOL, V139, P37 | - |
dc.description.citedreference | GUERIN C, 1992, BIOCHEM BIOPH RES CO, V188, P740 | - |
dc.description.citedreference | GOLUB LM, 1992, CURR OPIN DENT, V2, P80 | - |
dc.description.citedreference | TAMARGO RJ, 1991, CANCER RES, V51, P672 | - |
dc.description.citedreference | BRACKEN MB, 1991, J NEUROTRAUMA S1, V8, pS47 | - |
dc.description.citedreference | MARTIN RB, 1985, ANTIBIOTICS THEIR CO, P19 | - |
dc.description.citedreference | ARONSON AL, 1980, J AM VET MED ASSOC, V176, P1061 | - |
dc.description.tc | 77 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.